Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Foundations of Respiratory Medicine, 2018, p.331-350
Ort / Verlag
Switzerland: Springer International Publishing AG
Erscheinungsjahr
2018
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
The outcome of lung transplant recipients has progressively improved over the decades, related to improved candidate selection, the development of lung allocation policies, advances in surgical techniques, and an evolution of post-transplant care. A revision of the International Society for Heart and Lung Transplantation (ISHLT) criteria to guide referral and listing for lung transplantation is presented. Recent developments in post-transplant care are discussed, including the management of specific early and late transplant-related complications, specifically primary graft dysfunction, acute cellular and humoral rejection, infection, and chronic lung allograft dysfunction (CLAD). Effective immunosuppression is required, an awareness of drug interactions, and recognition of potential long-term adverse side effects. In the face of increasingly resistant micro-organisms, an effective anti-microbial strategy is required for optimum management. A revised classification of CLAD is discussed, including the established obstructive phenotype (Bronchiolitis Obliterans Syndrome, BOS) and a more recently described restrictive phenotype (Restrictive Allograft Syndrome, RAS), with its significant impact on long-term survival.